Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: unclear death in the home; she may have fallen; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB SE-MPA-2021-021308. Safety Report Unique Identifier SE-MPA-1616078200533. An 80-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration in Mar2021 (Batch/Lot number was not reported) as 0.3 mL, single for COVID-19 immunization. Medical history included hypertension, renal failure, hospitalized for 2 days for suspected TIA (transient ischemic attack) from 23Feb2021, weakness left or right side, cerebral stroke in 2004, and cardiac failure. Concomitant medications included furosemide (IMPUGAN), clopidogrel, colecalciferol (DIVISUN), budesonide, formoterol fumarate (SYMBICORT), atorvastatin, tiotropium bromide (SPIRIVA), allopurinol, and omeprazole. The patient experienced unclear death in the home in Mar2021. The woman had recently been hospitalized for 2 days for suspected TIA (transient ischemic attack). Almost two weeks later, the woman was vaccinated with Comirnaty. A relative tried to reach the patient on the phone eight days later, but got no answer. The next day, the home care staff find her lying dead on the bathroom floor, according to the reporter, she may have fallen. Outcome: Fatal. Report assessed as serious, death. Autopsy will not be performed. No follow-up attempts are possible, information on batch number cannot be obtained.; Reported Cause(s) of Death: unclear death in the home; she may have fallen
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166